Skip to content

Morphological Markers of Gastroesophageal Reflux Disease (GERD)

Dilation of Intercellular Spaces as Morphological Markers of Gastroesophageal Reflux Disease (GERD)In Children

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01921686
Enrollment
54
Registered
2013-08-13
Start date
2013-03-01
Completion date
2026-12-01
Last updated
2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic Esophagitis, Gastroesophageal Reflux Disease

Keywords

Eosinophil, Reflux, Esophagus, Food allergy, Trouble Swallowing, Pediatrics, Healthy Volunteers

Brief summary

The purpose of this project is to learn more about a new and promising way to diagnose acid reflux disease using a very high-powered microscope. This special microscope provides much finer detail than typical microscopes previously used for diagnosing reflux, and may help doctors to better identify children with acid reflux.

Detailed description

This will be a prospective case control study. Children between the ages of 8 and 18 with suspected gastroesophageal reflux disease (GERD) or eosinophilic esophagitis (EoE) based on symptom criteria and who have been scheduled for esophagogastroduodenoscopy (EGD) by their primary gastroenterologist will be recruited. Children who do not have any history of esophageal disease or esophageal symptoms and are scheduled for EGD for other clinical indications (e.g. rule out celiac disease) by their primary gastroenterologist will be recruited and act as controls. Control subjects will also be given the opportunity to undergo esophageal MII-pH monitoring as part of their medical evaluation, but will not be excluded from analysis should they opt out of this part of the study. For all subjects, in addition to endoscopic evaluation, biopsies of the distal esophagus will be obtained for routine light microscopy (standard histology sample) as well as Transmission Electron Microscopy (TEM) analysis to determine the presence and magnitude of dilated intercellular spaces (DIS), and immunoblotting for e-cadherin cleavage

Interventions

OTHERSample collection and Questionnaire

This is an observational biospecimen collection and questionnaire study. The subjects will be asked to complete a symptom questionnaire at screening visit. In addition, 3 esophageal biopsy samples will be taken to conduct laboratory analyses.

Sponsors

Baylor College of Medicine
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

for GERD or EoE Subjects: * Children between the ages of 8-18 years * Suspected diagnosis of GERD or EoE based on symptom criteria * Able to tolerate upper endoscopy examination with biopsies Inclusion Criteria for Control Subjects: * Children between the ages of 8-18 * Scheduled for EGD for clinical indications * No history of esophageal disease of esophageal symptoms * Able to tolerate upper endoscopy examination with biopsies

Exclusion criteria

for GERD or EoE Subjects: * History of Barrett's esophagus * Previous esophageal or gastric surgery * History of congenital defect/malformation of the esophagus * Diagnosis of Crohn disease

Design outcomes

Primary

MeasureTime frameDescription
TEM analysisat time of sample collectionUsing transmission electron microscopy (TEM), compare mean Dilated Intercellular Space diameter of esophageal epithelium in children with GERD to children with Eosinophilic Esophagitis and normal controls.

Secondary

MeasureTime frameDescription
pH monitoring24 hoursEvaluate the correlation between mean Dilated Intercellular Spaces diameter and quantitative reflux parameters determined by 24-hour esophageal multichannel intraluminal impedance-pH (MII-pH) monitoring

Countries

United States

Contacts

PRINCIPAL_INVESTIGATOREric H Chiou, MD

Baylor College of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 18, 2026